VIRTUAL LESIONS OF THE IFG ABOLISH RESPONSE FACILITATION FOR BIOLOGICAL AND NON-BIOLOGICAL CUES





Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore

Abstract Background Trastuzumab has revolutionized the way we treat early Her2Neu-positive breast cancer, as it significantly improves disease-free and overall survival.Little is known about the societal costs and benefits of treatment with trastuzumab in the adjuvant setting in Southeast Asia.Methods Societal costs (benefits) were estimated as the

read more